Yuzhe Xing

发表

Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.

K. Svenson, J. Bard, T. Mansour, 2009, Journal of medicinal chemistry.

β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action

J. McKew, T. Mansour, J. Xiang, 2007 .

Synthesis and biological evaluation of sulfonamidooxazoles and β-keto sulfones: selective inhibitors of 11β-hydroxysteroid dehydrogenase type I

J. Xiang, M. Tam, J. Tobin, 2005 .

Ertiprotafib Improves Glycemic Control and Lowers Lipids via Multiple Mechanisms

L. Klaman, M. Tam, Yan-ling Zhang, 2005, Molecular Pharmacology.

Antibodies to B7.1 define the GFCC'C" face of the N-terminal domain as critical for co-stimulatory interactions.

Yuzhe Xing, G. Veldman, D. Erbe, 2002, Immunology letters.

Small Molecule Ligands Define a Binding Site on the Immune Regulatory Protein B7.1*

Yuzhe Xing, D. Erbe, J. Tobin, 2002, The Journal of Biological Chemistry.

Piperazine sulfonamides as potent, selective, and orally available 11beta-hydroxysteroid dehydrogenase type 1 inhibitors with efficacy in the rat cortisone-induced hyperinsulinemia model.

J. McKew, T. Mansour, J. Xiang, 2008, Journal of medicinal chemistry.

beta-Keto sulfones as inhibitors of 11beta-hydroxysteroid dehydrogenase type I and the mechanism of action.

J. McKew, T. Mansour, J. Xiang, 2007, Bioorganic & medicinal chemistry.

Synthesis and biological evaluation of sulfonamidooxazoles and beta-keto sulfones: selective inhibitors of 11beta-hydroxysteroid dehydrogenase type I.

J. Xiang, M. Tam, J. Tobin, 2005, Bioorganic & Medicinal Chemistry Letters.